Exploring the Best Treatment Option for Initial C. diff Infection In Pediatric Patients
April 20th 2018Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.
Novavax Presents Data on Trials for Improved Flu Vaccine and Candidate for First RSV Vaccine
April 10th 2018Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.